CIBRN Poll #3: The introduction and promotion of biosimilar medications is fueled by a need to lower the overall cost of healthcare delivery. Where do you think we should be looking for cost savings?

If you haven’t yet participated in the poll, we invite you to share your views. Click here to answer.

The introduction and promotion of biosimilar medications is fueled by a need to lower the overall cost of healthcare delivery. Where do you think we should be looking for cost savings? Select one or more.

  • Hospitals
  • Physicians
  • Prescription Drugs
  • Long-term Care
  • Community Care
  • Other

Click here to answer